Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The University of Texas Health Science Center at San Antonio
M.D. Anderson Cancer Center
Washington University School of Medicine
Washington University School of Medicine
Yale University
Baptist Health South Florida
Maastricht University Medical Center
GCS Ramsay Santé pour l'Enseignement et la Recherche
Tianjin Medical University Cancer Institute and Hospital
Vanderbilt-Ingram Cancer Center
The Cooper Health System
Exelixis
Duke University
King's College Hospital NHS Trust
University of California, San Francisco
Medical University of Warsaw
Insel Gruppe AG, University Hospital Bern
OHSU Knight Cancer Institute
Dana-Farber Cancer Institute
The Methodist Hospital Research Institute
Hospital del Rio Hortega
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
Zhejiang Cancer Hospital
Medical College of Wisconsin
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Medical College of Wisconsin
University of Cincinnati